<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) represent a frequent complication of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To elucidate HIV-NHL pathogenesis, we performed a genome-wide DNA profiling based on a single nucleotide polymorphism-based microarray comparative genomic hybridization in 57 HIV-<z:hpo ids='HP_0002665'>lymphomas</z:hpo> and, for comparison, in 105 immunocompetent diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (IC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Genomic complexity varied across HIV-NHL subtypes </plain></SENT>
<SENT sid="3" pm="."><plain>HIV-Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> showed a significantly lower number of lesions than HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (P = 0.032), whereas the median number of copy number changes was significantly higher in Epstein-Barr virus negative (EBV-) HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (42.5, range 8-153) compared to EBV+ cases (22; range 3-41; P = 0.029) </plain></SENT>
<SENT sid="4" pm="."><plain>Compared to IC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> displayed a distinct genomic profile with no gains of 18q and specific genetic lesions </plain></SENT>
<SENT sid="5" pm="."><plain>Fragile sites-associated genes, including FHIT (FRA3B), WWOX (FRA16D), <z:chebi fb="8" ids="53090">DCC</z:chebi> (FRA18B) and PARK2 (FRA6E) were frequently inactivated in HIV-NHL by interstitial deletions, and a significantly higher prevalence of FHIT alterations was observed in HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> compared to IC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The same genes involved by fragile site deletions were also frequently affected by aberrant methylation of regulative regions </plain></SENT>
</text></document>